Annual Drug Patent Expirations for LATISSE Latisse is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are eleven patents protecting…
The post New patent expiration for Allergan drug LATISSE appeared firs…
ORILISSA (elagolix sodium) Abbvie inc Patent: 7,462,625 Expiration: Jan 25, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug Pate…
Drug Patent Expirations for the Week of January 24, 2021 Read Post »
Annual Drug Patent Expirations for BRIDION Bridion is a drug marketed by Organon Sub Merck and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Organon Sub drug BRIDION appeared first on Dru…
New patent expiration for Organon Sub drug BRIDION Read Post »
Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Abbvie Inc drug ORILISSA appeared first on …
New patent expiration for Abbvie Inc drug ORILISSA Read Post »
Annual Drug Patent Expirations for ORIAHNN+%28COPACKAGED%29 Oriahnn (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Abbvie Inc drug ORIAHNN …
New patent expiration for Abbvie Inc drug ORIAHNN (COPACKAGED) Read Post »
Annual Drug Patent Expirations for HALAVEN Halaven is a drug marketed by Eisai Inc and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for Eisai Inc drug HALAVEN appeared first on Drug…
New patent expiration for Eisai Inc drug HALAVEN Read Post »
Annual Drug Patent Expirations for HALAVEN Halaven is a drug marketed by Eisai Inc and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for Eisai Inc drug HALAVEN appeared first on Drug…
New patent expiration for Eisai Inc drug HALAVEN Read Post »
CARNITOR (levocarnitine) Leadiant biosci inc Patent: 6,696,493 Expiration: Jan 18, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dr…
Drug Patent Expirations for the Week of January 17, 2021 Read Post »
CARNITOR (levocarnitine) Leadiant biosci inc Patent: 6,696,493 Expiration: Jan 18, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dr…
Drug Patent Expirations for the Week of January 17, 2021 Read Post »
CARNITOR (levocarnitine) Leadiant biosci inc Patent: 6,696,493 Expiration: Jan 18, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dr…
Drug Patent Expirations for the Week of January 17, 2021 Read Post »